Searchable abstracts of presentations at key conferences in endocrinology

ea0081p655 | Pituitary and Neuroendocrinology | ECE2022

Congenital combined pituitary hormone deficiency associated with primary ovarian insufficiency: a case report

terzi Ameni , Khessairi Nadia , mouelhi yasmine , Chaker Fatma , Chihaoui Melika

Introduction: Congenital combined pituitary hormone deficiency (CCPHD) is a rare disorder characterized by an impaired production of two or more hormones of the anterior pituitary gland. It is linked to different genetic mutations and requires an early diagnosis to prevent burdensome developmental consequences. Primary ovarian insufficiency, disparately is the depletion of ovarian function with loss of functional primordial follicles before the age of 40 years due to multiple ...

ea0081ep56 | Adrenal and Cardiovascular Endocrinology | ECE2022

Cushing disease in patient with chronic renal failure treated by hemodialysis: a case report

Terzi Ameni , Khessairi Nadia , Mouelhi Yasmine , Yazidi Meriem , Chihaoui Melika

Introduction: The occurrence of Cushing’s syndrome in individuals with chronic renal failure is notably rare. It represents a challenging diagnosis in the context of pre-existing chronic kidney disease due to commonly associated alterations in the hypothalamic–pituitary–adrenal axis function. Consequently, the interpretation of standard tests used to detect hypercortisolism can be peculiarly difficult and reveal concrete particularities in comparison to patients...

ea0081ep800 | Pituitary and Neuroendocrinology | ECE2022

Hyperprolactinemia, thyrotropic and corticotropic insufficiency in a patient with end-stage renal failure

Mouelhi Yasmine , Khessairi Nadia , Terzi Ameni , Yazidi Meriem , Chihaoui Melika

Introduction: Hyperprolactinemia is a condition of elevated prolactin levels in blood which could be physiological, pathological, or idiopathic in origin. Some cases of hyperprolactinemia have been reported in patients with renal failure. We present a case of hyperprolactinemia, thyrotropic and corticotropic insufficiency in a patient with end-stage renal failure.Case presentation: The patient was 27 years old, with a history of hypertension, renal insuf...

ea0081ep831 | Pituitary and Neuroendocrinology | ECE2022

Acromegaly in the elderly patients

Khelifi Dayssem , Khessairi Nadia , Terzi Ameni , Grira Wafa , Chihaoui Melika

Introduction: Pituitary adenomas in people over 65 represent less than 10% of all pituitary adenomas, 80% of which are non-functional. Somatotropic adenomas remain very rare. The interest of our study is to describe the clinical, paraclinical and therapeutic profile of cases of senile acromegaly.Patients and methods: This is a retrospective study of four senile acromegaly patients followed in our endocrinology’s department.Res...

ea0081p631 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Predictive factors of glycaemic control in type 2 diabetic patients during the COVID-19 crisis

Grassa Anis , Sliman Chayma Bel Hadj , Terzi Ameni , Khessairi Nadia , Yazidi Meriem , Oueslati Ibtissem , Chihaoui Melika

Introduction: Glycaemic control is still difficult to achieve despite advances in the pharmacotherapy of type 2 diabetes. Moreover, the COVID-19 crisis led to a disruption in medical consultations and in the access to medications. The aim of our study was to identify factors associated with poor glycaemic control in Tunisian type 2 diabetic patients during the COVID-19 crisis.Methods: This is a cross-sectional study, carried out in December 2021, on type...

ea0081p632 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Assessment of glycaemic control in type 2 diabetic patients before and during the COVID-19 crisis

Hadj Sliman Chayma Bel , Grassa Anis , Terzi Ameni , Khessairi Nadia , Chaker Fatma , Oueslati Ibtissem , Chihaoui Melika

Introduction: Chronic hyperglycemia in type 2 diabetic patients is associated with an increased risk of micro and macrovascular complications. Therefore, glycemic control is the cornerstone of its management. The aim of this study was to evaluate glycemic control in patients with type 2 diabetes before and during COVID-19 crisis.Methods: A cross-sectional study was conducted during December 2021, in the outpatient clinic of the department of endocrinolog...

ea0081ep527 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Effective treatment of allergy to the insulin excipient meta-cresol with desensitization therapy in type 1 diabetes mellitus: a case report.

Terzi Ameni , Yazidi Meriem , Grassa Anis , Khessairi Nadia , Grira Wafa , Oueslati Ibtissem , Chihaoui Melika

Introduction: Insulin allergy is a clinical challenge in the management of type 1 diabetes mellitus since there is no other therapeutic alternative. The specific cause of insulin allergy can be related to insulin itself or to additives including zinc, protamine and meta-cresol. The manifestations range from localized reactions to systemic severe anaphylaxis. We here present the case of a generalized allergy to insulin excipient meta-cresol, in a type 1 diabetic patient success...

ea0081ep916 | Reproductive and Developmental Endocrinology | ECE2022

Swyer syndrome presenting with clinical features of cushing disease: a case report

Terzi Ameni , Yazidi Meriem , Chehaider Cyrine , Oueslati Ibtissem , Chaker Fatma , Chihaoui Melika

Introduction: Swyer syndrome is a rare sex development disorder characterized by pure 46 XY gonadal dysgenesis. It is associated with aberrations in testicular determination and differentiation leading to a female morphotype with presence of external and internal female genitalia, undifferentiated fibrous gonads, a male karyotype and hypergonadotropic hypogonadism. We present the case of a 46 XY adolescent female with complete gonadal dysgenesis diagnosed following her hospita...

ea0081ep1162 | Thyroid | ECE2022

Hypothyroidism : the interest of thyroid hormone test

Mouelhi Yasmine , Khessairi Nadia , Terzi Ameni , Grira Wafa , Yazidi Meriem , Chihaoui Melika

Introduction: Hypothyroidism is a common endocrine disease with reduced systemic metabolism and its treatment consists on hormonal supplementation. However, despite concurrent replacement therapy with high doses of L-thyroxin, some patients might be seen with clinical and biochemical evidence of hypothyroidism. We report a case of persistent hypothyroidism on high dose of levothyroxin.Case presentation: It was a 41-year-old female, with a history of recu...

ea0090p146 | Pituitary and Neuroendocrinology | ECE2023

Dopamine agonist-resistance in patients with macroprolactinoma: prevalence and predictive factors

Terzi Ameni , Oueslati Ibtissem , Hadj Sliman Chayma Bel , Abid Arige , Yazidi Meriem , Chihaoui Melika

Introduction: Dopamine agonists, mainly cabergoline and bromocriptine, represent the first-line treatment option in the management of prolactinomas. They allow prolactin normalization and tumor shrinkage. However, a subset of individuals with macroprolactinoma could exhibit a varying degree of resistance to dopamine agonists. The aim of this study was to determine the prevalence of dopamine agonist-resistance in patients with macroprolactinoma and to assess its predictive fact...